Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

Testosterone may both worsen and protect against COVID-19 effects in men.

COVID-19 doesn't make alopecia areata worse.

Hispanics in Northern Nevada had more COVID-19 cases but lower mortality than non-Hispanics.

Men had worse COVID-19 outcomes than women in New York City.

Extra virgin olive oil may boost the immune system and help fight infections like COVID-19.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

A COVID-19 patient had unusual nail discoloration and nail separation possibly due to the virus's effects on small blood vessels.

Hispanic individuals in Northern Nevada were more affected by COVID-19 but had lower mortality rates than non-Hispanics.

Minoxidil and Finasteride are the most popular hair loss treatments, with rising interest in other options, and economic or health crises can change what treatments people prefer.

Skin symptoms linked to COVID-19 are hard to confirm, and more testing is needed to identify which are truly caused by the virus.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Hair loss doesn't affect COVID-19 severity.

There's no significant genetic link between male pattern baldness and COVID-19.

Low testosterone may increase COVID-19 severity in men.

PHAT may improve hair growth better than PRP alone.

PCOS women with COVID-19 have higher cardiometabolic risks.

High incidence of hair loss found in COVID-19 patients, but no severity correlation established.

Non-hospitalized COVID-19 patients often have lingering symptoms for at least 30 days.

The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.

Health workers in non-COVID wards had higher depression and anxiety rates.

The COVID-19 pandemic led to fewer dermatology visits, older and more male patients, and more stress-related skin issues.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.

Medicinal plants might help with post-COVID-19 issues, but more research is needed.

Resident doctors had more facial skin discoloration than medical students during COVID-19.